Literature DB >> 19423473

Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study.

S Esposito1, S Leone, S Noviello, F Ianniello, M Russo, G Foti, M S Carpentieri, C Cellesi, G Zanelli, A Cellini, C Girmenia, F De Lalla, A Maiello, P Maio, N Acone, F Marranconi, S Sabbatani, M Pantaleoni, F Ghinelli, M L Soranzo, P Viganò, T Re, P Viale, L Scudeller.   

Abstract

Bacterial infections are the most frequent cause of hospitalization in elderly patients. In the early eighties, the advantages of Outpatient parenteral Antibiotic therapy (OPAT) were identified in the United States, and suitable therapeutic programs were established. In order to understand the different ways of managing OPAT, a National OPAT Registry was set up in 2003 in Italy. This study analyzes data concerning bacterial infections in 176 elderly patients including demographics, therapeutic management, clinical response, and side-effects. Bone and joint infections (48.9%) and skin and soft tissue infections (27.8%) were the most common infections treated with OPAT. Teicoplanin (28.9%) and ceftriaxone (22.1%) were the top two antibiotics chosen. OPAT was mainly performed at a hospital infusion center (52.8%). The clinical success rate was high and side-effects were low (12.6% of cases). Management of bacterial infections in the elderly with an outpatient program is effective and safe.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19423473     DOI: 10.1179/joc.2009.21.2.193

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  3 in total

1.  Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece.

Authors:  G Theocharis; P I Rafailidis; D Rodis; I Kontopidis; S G Barbas; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-02       Impact factor: 3.267

Review 2.  Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.

Authors:  E D Mitchell; C Czoski Murray; D Meads; J Minton; J Wright; M Twiddy
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

3.  Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997-2017.

Authors:  Ann Versporten; Robin Bruyndonckx; Niels Adriaenssens; Niel Hens; Dominique L Monnet; Geert Molenberghs; Herman Goossens; Klaus Weist; Samuel Coenen
Journal:  J Antimicrob Chemother       Date:  2021-07-26       Impact factor: 5.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.